The country reported 1,68,063 new COVID-19 cases in the last 24 hours, the Ministry of Health and Family Welfare informed on January 11
According to the Health Ministry, Molnupiravir is an antiviral drug that inhibits SARS-CoV-2 replication by viral mutagenesis
The (COVID-19) situation is dynamic and evolving. Therefore, the need for hospitalisation may also change rapidly, said Union Health Secretary Rajesh Bhushan
IIT professor Manindra Agrawal said that the COVID-19 cases will overtake the cases recorded during the second wave
Internationally renowned sand artist, Sudarsan Pattnaik creates a new artwork to raise awareness about Covid protocols and vaccination
While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as ‘mild’, said...
As per the latest guidelines, isolation at home cut to 7 days from 10 days, asymptomatic contacts do not need to be tested
Since the Omicron variant is 5.4 times more infectious than the Delta variant, infections among doctors are expected to be five to 10 times more than...
डब्ल्यूएचओ (WHO) की मुख्य वैज्ञानिक डॉ सौम्या स्वामीनाथन ने ओमिक्रोन उछाल के बीच भारत में चिकित्सा सुविधाओं को बढ़ाने की बात की
According to the experts, the hospitalisation due to COVID-19 has increased in the recent past but none of the patients are in a serious state but...
Dr NK Arora said that the galloping increase in the number of Covid cases over the last one week is indicative of the third wave
Molnupiravir is the oral antiviral for the treatment of mild to moderate COVID-19 in adults
